VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q58880069  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235919.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q58880069‏
024 ‎‡a  0000-0002-2044-2397‏ ‎‡2  orcid‏
024 ‎‡a  35098154500‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q58880069‏
100 0 ‎‡a  Mónica Calderón-Santiago‏ ‎‡c  researcher ORCID ID = 0000-0002-2044-2397‏ ‎‡9  en‏
400 0 ‎‡a  Mónica Calderón-Santiago‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Analysis of serum phospholipid profiles by liquid chromatography-tandem mass spectrometry in high resolution mode for evaluation of atherosclerotic patients.‏
670 ‎‡a  Author's Analytical platform for verification and quantitation of target peptides in human serum: application to cathelicidin‏
670 ‎‡a  Author's Cholesterol oxidation products in milk: Processing formation and determination‏
670 ‎‡a  Author's Confirmatory and quantitative analysis of fatty acid esters of hydroxy fatty acids in serum by solid phase extraction coupled to liquid chromatography tandem mass spectrometry‏
670 ‎‡a  Author's Determination of essential amino acids in human serum by a targeting method based on automated SPE-LC-MS/MS: discrimination between artherosclerotic patients‏
670 ‎‡a  Author's Determination of fatty acids and stable carbon isotopic ratio in subcutaneous fat to identify the feeding regime of Iberian pigs‏
670 ‎‡a  Author's Development of a method for enhancing metabolomics coverage of human sweat by gas chromatography-mass spectrometry in high resolution mode‏
670 ‎‡a  Author's Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography-mass spectrometry in high resolution mode.‏
670 ‎‡a  Author's Enhanced detection and identification in metabolomics by use of LC-MS/MS untargeted analysis in combination with gas-phase fractionation‏
670 ‎‡a  Author's Enhancing detection coverage in untargeted metabolomics analysis by solid-phase extraction on-line coupled to LC-MS/MS.‏
670 ‎‡a  Author's Exhaled breath condensate to discriminate individuals with different smoking habits by GC-TOF/MS‏
670 ‎‡a  Author's High-resolution mass spectrometry to evaluate the influence of cross-breeding segregating populations on the phenolic profile of virgin olive oils‏
670 ‎‡a  Author's Human sweat metabolomics for lung cancer screening‏
670 ‎‡a  Author's Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate.‏
670 ‎‡a  Author's Influence of sample preparation on lipidomics analysis of polar lipids in adipose tissue.‏
670 ‎‡a  Author's Influence of the collection tube on metabolomic changes in serum and plasma.‏
670 ‎‡a  Author's Integrated proteomic and metabolomic analysis reveals that rhodomyrtone reduces the capsule in Streptococcus pneumoniae.‏
670 ‎‡a  Author's Metabolomic discrimination between patients with stable angina, non-ST elevation myocardial infarction, and acute myocardial infarct‏
670 ‎‡a  Author's Metabolomics analysis of exhaled breath condensate for discrimination between lung cancer patients and risk factor individuals.‏
670 ‎‡a  Author's Metabolomics analysis of human sweat collected after moderate exercise.‏
670 ‎‡a  Author's MetaboQC: A tool for correcting untargeted metabolomics data with mass spectrometry detection using quality controls‏
670 ‎‡a  Author's Method based on GC-MS to study the influence of tricarboxylic acid cycle metabolites on cardiovascular risk factors.‏
670 ‎‡a  Author's Optimization study for metabolomics analysis of human sweat by liquid chromatography–tandem mass spectrometry in high resolution mode‏
670 ‎‡a  Author's Profiling analysis of phospholipid fatty acids in serum as a complement to the comprehensive fatty acids method‏
670 ‎‡a  Author's Prostate Cancer Patients-Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics‏
670 ‎‡a  Author's Quantitative determination and confirmatory analysis of N-acetylneuraminic and N-glycolylneuraminic acids in serum and urine by solid-phase extraction on-line coupled to liquid chromatography–tandem mass spectrometry‏
670 ‎‡a  Author's Study of exhaled breath condensate sample preparation for metabolomics analysis by LC-MS/MS in high resolution mode.‏
670 ‎‡a  Author's Study of sample preparation for quantitative analysis of amino acids in human sweat by liquid chromatography-tandem mass spectrometry.‏
670 ‎‡a  Author's The dual trend in histatins research‏
670 ‎‡a  Author's Untargeted analysis to monitor metabolic changes of garlic along heat treatment by LC-QTOF MS/MS.‏
909 ‎‡a  (orcid) 0000000220442397‏ ‎‡9  1‏
909 ‎‡a  (scopus) 35098154500‏ ‎‡9  1‏
919 ‎‡a  enhanceddetectionandidentificationinmetabolomicsbyuseoflcmsmsuntargetedanalysisincombinationwithgasphasefractionation‏ ‎‡A  Enhanced detection and identification in metabolomics by use of LC-MS/MS untargeted analysis in combination with gas-phase fractionation‏ ‎‡9  1‏
919 ‎‡a  enhancingdetectioncoverageinuntargetedmetabolomicsanalysisbysolidphaseextractiononlinecoupledtolcmsms‏ ‎‡A  Enhancing detection coverage in untargeted metabolomics analysis by solid-phase extraction on-line coupled to LC-MS/MS.‏ ‎‡9  1‏
919 ‎‡a  exhaledbreathcondensatetodiscriminateindividualswithdifferentsmokinghabitsbygctofms‏ ‎‡A  Exhaled breath condensate to discriminate individuals with different smoking habits by GC-TOF/MS‏ ‎‡9  1‏
919 ‎‡a  highresolutionmassspectrometrytoevaluatetheinfluenceofcrossbreedingsegregatingpopulationsonthephenolicprofileofvirginoliveoils‏ ‎‡A  High-resolution mass spectrometry to evaluate the influence of cross-breeding segregating populations on the phenolic profile of virgin olive oils‏ ‎‡9  1‏
919 ‎‡a  humansweatmetabolomicsforlungcancerscreening‏ ‎‡A  Human sweat metabolomics for lung cancer screening‏ ‎‡9  1‏
919 ‎‡a  identificationofmetabolomicspanelsforpotentiallungcancerscreeningbyanalysisofexhaledbreathcondensate‏ ‎‡A  Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate.‏ ‎‡9  1‏
919 ‎‡a  influenceofsamplepreparationonlipidomicsanalysisofpolarlipidsinadiposetissue‏ ‎‡A  Influence of sample preparation on lipidomics analysis of polar lipids in adipose tissue.‏ ‎‡9  1‏
919 ‎‡a  influenceofthecollectiontubeonmetabolomicchangesinserumandplasma‏ ‎‡A  Influence of the collection tube on metabolomic changes in serum and plasma.‏ ‎‡9  1‏
919 ‎‡a  integratedproteomicandmetabolomicanalysisrevealsthatrhodomyrtonereducesthecapsuleinstreptococcuspneumoniae‏ ‎‡A  Integrated proteomic and metabolomic analysis reveals that rhodomyrtone reduces the capsule in Streptococcus pneumoniae.‏ ‎‡9  1‏
919 ‎‡a  metabolomicdiscriminationbetweenpatientswithstableanginanonstelevationmyocardialinfarctionandacutemyocardialinfarct‏ ‎‡A  Metabolomic discrimination between patients with stable angina, non-ST elevation myocardial infarction, and acute myocardial infarct‏ ‎‡9  1‏
919 ‎‡a  metabolomicsanalysisofexhaledbreathcondensatefordiscriminationbetweenlungcancerpatientsandriskfactorindividuals‏ ‎‡A  Metabolomics analysis of exhaled breath condensate for discrimination between lung cancer patients and risk factor individuals.‏ ‎‡9  1‏
919 ‎‡a  metabolomicsanalysisofhumansweatcollectedaftermoderateexercise‏ ‎‡A  Metabolomics analysis of human sweat collected after moderate exercise.‏ ‎‡9  1‏
919 ‎‡a  metaboqcatoolforcorrectinguntargetedmetabolomicsdatawithmassspectrometrydetectionusingqualitycontrols‏ ‎‡A  MetaboQC: A tool for correcting untargeted metabolomics data with mass spectrometry detection using quality controls‏ ‎‡9  1‏
919 ‎‡a  methodbasedongcmstostudytheinfluenceoftricarboxylicacidcyclemetabolitesoncardiovascularriskfactors‏ ‎‡A  Method based on GC-MS to study the influence of tricarboxylic acid cycle metabolites on cardiovascular risk factors.‏ ‎‡9  1‏
919 ‎‡a  optimizationstudyformetabolomicsanalysisofhumansweatbyliquidchromatographytandemmassspectrometryinhighresolutionmode‏ ‎‡A  Optimization study for metabolomics analysis of human sweat by liquid chromatography–tandem mass spectrometry in high resolution mode‏ ‎‡9  1‏
919 ‎‡a  profilinganalysisofphospholipidfattyacidsinserumasacomplementtothecomprehensivefattyacidsmethod‏ ‎‡A  Profiling analysis of phospholipid fatty acids in serum as a complement to the comprehensive fatty acids method‏ ‎‡9  1‏
919 ‎‡a  prostatecancerpatientsnegativebiopsycontrolsdiscriminationbyuntargetedmetabolomicsanalysisofurinebylcqtofupstreaminformationonotheromics‏ ‎‡A  Prostate Cancer Patients-Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics‏ ‎‡9  1‏
919 ‎‡a  quantitativedeterminationandconfirmatoryanalysisofnacetylneuraminicandnglycolylneuraminicacidsinserumandurinebysolidphaseextractiononlinecoupledtoliquidchromatographytandemmassspectrometry‏ ‎‡A  Quantitative determination and confirmatory analysis of N-acetylneuraminic and N-glycolylneuraminic acids in serum and urine by solid-phase extraction on-line coupled to liquid chromatography–tandem mass spectrometry‏ ‎‡9  1‏
919 ‎‡a  studyofexhaledbreathcondensatesamplepreparationformetabolomicsanalysisbylcmsmsinhighresolutionmode‏ ‎‡A  Study of exhaled breath condensate sample preparation for metabolomics analysis by LC-MS/MS in high resolution mode.‏ ‎‡9  1‏
919 ‎‡a  untargetedanalysistomonitormetabolicchangesofgarlicalongheattreatmentbylcqtofmsms‏ ‎‡A  Untargeted analysis to monitor metabolic changes of garlic along heat treatment by LC-QTOF MS/MS.‏ ‎‡9  1‏
919 ‎‡a  dualtrendinhistatinsresearch‏ ‎‡A  The dual trend in histatins research‏ ‎‡9  1‏
919 ‎‡a  studyofsamplepreparationforquantitativeanalysisofaminoacidsinhumansweatbyliquidchromatographytandemmassspectrometry‏ ‎‡A  Study of sample preparation for quantitative analysis of amino acids in human sweat by liquid chromatography-tandem mass spectrometry.‏ ‎‡9  1‏
919 ‎‡a  analysisofserumphospholipidprofilesbyliquidchromatographytandemmassspectrometryinhighresolutionmodeforevaluationofatheroscleroticpatients‏ ‎‡A  Analysis of serum phospholipid profiles by liquid chromatography-tandem mass spectrometry in high resolution mode for evaluation of atherosclerotic patients.‏ ‎‡9  1‏
919 ‎‡a  analyticalplatformforverificationandquantitationoftargetpeptidesinhumanserumapplicationtocathelicidin‏ ‎‡A  Analytical platform for verification and quantitation of target peptides in human serum: application to cathelicidin‏ ‎‡9  1‏
919 ‎‡a  cholesteroloxidationproductsinmilkprocessingformationanddetermination‏ ‎‡A  Cholesterol oxidation products in milk: Processing formation and determination‏ ‎‡9  1‏
919 ‎‡a  confirmatoryandquantitativeanalysisoffattyacidestersofhydroxyfattyacidsinserumbysolidphaseextractioncoupledtoliquidchromatographytandemmassspectrometry‏ ‎‡A  Confirmatory and quantitative analysis of fatty acid esters of hydroxy fatty acids in serum by solid phase extraction coupled to liquid chromatography tandem mass spectrometry‏ ‎‡9  1‏
919 ‎‡a  determinationofessentialaminoacidsinhumanserumbyatargetingmethodbasedonautomatedspelcmsmsdiscriminationbetweenartheroscleroticpatients‏ ‎‡A  Determination of essential amino acids in human serum by a targeting method based on automated SPE-LC-MS/MS: discrimination between artherosclerotic patients‏ ‎‡9  1‏
919 ‎‡a  determinationoffattyacidsandstablecarbonisotopicratioinsubcutaneousfattoidentifythefeedingregimeofiberianpigs‏ ‎‡A  Determination of fatty acids and stable carbon isotopic ratio in subcutaneous fat to identify the feeding regime of Iberian pigs‏ ‎‡9  1‏
919 ‎‡a  developmentofamethodforenhancingmetabolomicscoverageofhumansweatbygaschromatographymassspectrometryinhighresolutionmode‏ ‎‡A  Development of a method for enhancing metabolomics coverage of human sweat by gas chromatography-mass spectrometry in high resolution mode‏ ‎‡9  1‏
919 ‎‡a  developmentofamethodformetabolomicanalysisofhumanexhaledbreathcondensatebygaschromatographymassspectrometryinhighresolutionmode‏ ‎‡A  Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography-mass spectrometry in high resolution mode.‏ ‎‡9  1‏
996 ‎‡2  PTBNP|1038925
996 ‎‡2  ISNI|0000000068511625
996 ‎‡2  SUDOC|17878902X
996 ‎‡2  PTBNP|42544
996 ‎‡2  LC|n 2019004847
996 ‎‡2  ISNI|0000000069991149
996 ‎‡2  BNE|XX5428781
996 ‎‡2  ISNI|0000000495815949
996 ‎‡2  PLWABN|9810635672605606
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏